EQS-News: MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May
|
EQS-News: MEDICLIN AG
/ Key word(s): Expansion/Contract
Offenburg, 2 May 2024
MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May Offenburg, 2 May 2024: On 1 May, the operation of the Reha-Klinik am Sendesaal was transferred to MEDICLIN. A symbolic handover of the key between MEDICLIN COO Thomas Piefke, clinic managing director and regional managing director Holger Kammann and Heinz Beekmann, managing director of the Specht Group, took place on Monday. Beekmann presented the "Bremen Key" made of acrylic glass to the MEDICLIN representatives in front of the rehabilitation clinic. At the beginning of April, representatives of MEDICLIN and the Specht Group signed the purchase agreement for the clinic. The clinic will now operate under the name "MEDICLIN Reha-Klinik am Sendesaal". "We extend a warm welcome to the employees in Bremen," says MEDICLIN CEO Dr Joachim Ramming. "MEDICLIN has facilities throughout Germany in various areas - rehabilitation, acute care, nursing care, MVZs - but our core competence is and remains rehabilitation." Piefke adds: "We want to continue to grow in the rehabilitation sector, both inpatient and outpatient. We are delighted that the Reha-Klinik am Sendesaal is now part of the MEDICLIN family!" For further information: MEDICLIN Aktiengesellschaft Okenstrasse 27 77652 Offenburg Germany Investor Relations Ender Gülcan Phone: 0781/488-326 ender.guelcan@mediclin.de Public Relations Dr Janina Lossen Phone: 0781/488-180 janina.lossen@mediclin.de www.mediclin.de About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510) MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs. MEDICLIN ─ a company of the Asklepios Group
02.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | MEDICLIN AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-326 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | ender.guelcan@mediclin.de |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1894351 |
| End of News | EQS News Service |
|
|
1894351 02.05.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 645,11 | 673,09 | 659,86 | 673,14 | 704,70 | 730,07 | 759,00 | |
| EBITDA1,2 | 37,35 | 93,58 | 77,50 | 85,22 | 90,92 | 98,73 | 127,00 | |
| EBITDA-Margin3 | 5,79 | 13,90 | 11,75 | 12,66 | 12,90 | 13,52 | 16,73 | |
| EBIT1,4 | 15,06 | 22,41 | 0,15 | 11,56 | 19,52 | 12,72 | 42,00 | |
| EBIT-Margin5 | 2,33 | 3,33 | 0,02 | 1,72 | 2,77 | 1,74 | 5,53 | |
| Net Profit (Loss)1 | 7,76 | 9,68 | -0,04 | 1,49 | 9,72 | -10,72 | 18,00 | |
| Net-Margin6 | 1,20 | 1,44 | -0,01 | 0,22 | 1,38 | -1,47 | 2,37 | |
| Cashflow1,7 | 29,77 | 69,59 | 118,69 | 81,97 | 34,64 | 78,00 | 0,00 | |
| Earnings per share8 | 0,16 | 0,20 | -0,19 | 0,03 | 0,20 | -0,23 | 0,38 | |
| Dividend per share8 | 0,05 | 0,05 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Mediclin | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 659510 | DE0006595101 | AG | 116,85 Mio € | 06.12.2000 | Halten | 8FW9FWGV+63 |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 9,46 | 19,13 | 0,49 | 18,50 | 0,60 | 1,50 | 0,16 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 04.06.2025 | 02.05.2025 | 31.07.2025 | 04.11.2024 | 28.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,20% | -3,61% | -10,22% | -7,52% | -77,64% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
